Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Liver Cancer|October 21, 2020
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular CarcinomaKazuomi Ueshima, Sadahisa Ogasawara, Masafumi Ikeda, et al.
Molecular Genetics and Metabolism|May 11, 2025
Dual pathogenic mechanisms in lysinuric protein intolerance: Interplay between hyperammonemia and cellular metabolic dysregulation in astrocyte injuryKeisuke Kakisaka, Takuro Sato, Yasunori Wada, et al.
Liver Cancer|October 30, 2023
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept StudyMasatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, et al.
Journal of Gastroenterology|July 1, 2025
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapyTakanori Suzuki, Kentaro Matsuura, Yuki Tahata, et al.
Cancer Medicine|October 15, 2025
A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced StageMasashi Ninomiya, Mio Tsuruoka, Jun Inoue, et al.
Visual Computing for Industry, Biomedicine, and Art|August 14, 2025
Deep learning radiomics of elastography for diagnosing compensated advanced chronic liver disease: an international multicenter studyXue Lu, Haoyan Zhang, Hidekatsu Kuroda, et al.
Scientific Reports|November 25, 2023
A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stageMasashi Ninomiya, Mio Tsuruoka, Jun Inoue, et al.
Gastro Hep Advances|August 12, 2024
Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic ScoresKeisuke Kakisaka, Nobuaki Nakayama, Kotaro Kumagai, et al.
Journal of Gastroenterology|February 24, 2025
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter studyTakashi Nishimura, Toshifumi Tada, Tomoyuki Akita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 6, 2026
The Hepatic Steatosis Diagnostic Performance Using Attenuation Imaging With the Magnetic Resonance Imaging-Based Proton Density Fat Fraction as the Reference Standard: A Large, Prospective, Multicenter Cohort Study in JapanTakashi Nishimura, Hiroko Iijima, Yasuaki Suzuki, et al.
Pageof 14